Pharmacologic inhibition of the Twist1-BRD4 interaction with JQ1 or MS417 reduces WNT5A expression and suppresses cell invasion, CSC-like properties, and tumorigenicity in basal-like breast cancer cell lines (Shi et al., 2014). The gene discussed is BRD4; the disease is breast carcinoma.